- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 34.51M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 34.51M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 34.51M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $3.41K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$375.95K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$322.51K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $2.63M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $2.58M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $2.8M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $2.68M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $177.58K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $334.32K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $419.69K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $558.01K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.01M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.1M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.05M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $3.14M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $91.67K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $88.76K |
| Net Income | Q1 2024 · Mar 31, 2024 | $47.65K |
| Net Income | Q1 2024 · Mar 31, 2023 | $118.12K |
| Operating Income | Q1 2024 · Mar 31, 2024 | $56.9K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $158.31K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $488.11K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $711.82K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $316.79K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $425.14K |
| Revenue | Q1 2024 · Mar 31, 2024 | $804.9K |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.14M |